期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肢端肥大症性心肌病合并肺动脉瘤、二尖瓣脱垂一例

One case of acromegalic cardiomyopathy with pulmonary artery aneurysm and mitral valve prolapse
原文传递
导出
摘要 心血管并发症是肢端肥大症患者的主要死因，尤其是肢端肥大症性心肌病。早期诊断和有效控制生长激素能显著改善患者长期预后和生存率。但肢端肥大症性心肌病临床漏诊率非常高，且易与其他心脏病或其他心肌病的病因混淆，现将1例肢端肥大症性心肌病同时合并肺动脉瘤及二尖瓣脱垂的患者报道如下。
作者 桑震池 承解静 杨洁 杨晓燕 王丽敏 孙燕妮 刘军 曹和平
机构地区 上海中医药大学附属普陀医院心内科 上海中医药大学附属普陀医院急诊科
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2012年第3期242-243,共2页 Chinese Journal of Endocrinology and Metabolism
关键词 肢端肥大症性 二尖瓣脱垂 肺动脉瘤 心肌病 心血管并发症 主要死因 长期预后 生长激素
分类号 R542.2 [医药卫生—心血管疾病]
  • 相关文献

参考文献9

  • 1BatesAS, Van't Hoff W, Jones JM, et al. An audit of outcome of treatment in acromegaly. Q J Med, 1993,86:293-299.
  • 2McGuffin Jr WL, Sherman BM, Roth F, et al. Acromegaly and cardiovascular disorders. A prospective study. Ann Intern Med, 1974, 81:11-18.
  • 3Clayton RN. Cardiovascular function in acromegaly. Endocr Rev, 2003,24:272-277.
  • 4Corville C, Mason WR. The heart in acromegaly. Arch Intern Med, 1938,61:704-713.
  • 5余秋芳,白融,周强,严江涛,汪道文.肢端肥大症性心肌病二例的临床诊治和文献回顾[J].中华心血管病杂志,2010,38(4):354-356. 被引量：8
  • 6Colao A, Cuocolo A, Marzullo P, et al. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly. J Clin Endocrinol Metab, 1999,84 : 17-23.
  • 7Colao A, Cuocolo A, Marzullo P, et al. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulinlike growth factor I levels on cardiac performance. J Clin Endocrinol Metab, 2001,86 : 1551-1557.
  • 8Colao A, Marzullo P, Cuocolo A, et al. Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide. Clin Endocrinol( Oxf), 2003,58 : 169-176.
  • 9赵传龙,魏振宇,孙鹏飞,田茂洲.肢端肥大症合并二尖瓣脱垂一例[J].中国胸心血管外科临床杂志,2005,12(5):375-375. 被引量：1

二级参考文献16

  • 1马驰原,卢亦成,郑川玉,骆纯.肢端肥大症性心肌病的神经外科手术治疗[J].中华神经医学杂志,2005,4(3):257-258. 被引量：5
  • 2邹阳春,孟丽珍.肢端肥大症性心肌病（附2例报告）[J].新疆医学院学报,1995,18(1):21-22. 被引量：1
  • 3Bihan H,Espinosa C,Valdes-Socin H,et al.Long-term outcome of patients with acromegaly and congestive heart failure.J Clin Endocrinol Metab,2004,89:5308-5313.
  • 4Colao A,Marzullo P,Ferone D,et al.Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.J Clin Endocrinol Metab,2000,85:3132-3140.
  • 5Mutta MP,Caron P.Acromegalic cardiomyopathy:a review of the literature.Pituitary,2003,6:203-207.
  • 6Colao A,Cuocolo A,Marzullo P,et al.Is the acromegallc cardiomyopathy reversible?Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.J Clin Endocrinol Metab,2001,86:1551-1557.
  • 7Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology,Heart Failure and Transplantation Committee;Quality of Care and Outcomes Research and Functional Genomics and Transhtional Biology Interdisciplinary Working Groups;and Council on Epidemiology and Prevention.Circulation,2006,113:1807-1816.
  • 8Twickler M,Cramer MJ,van Dam PS,et al.Significant improvement of acromegaly-induced cardiomyopathy after normalization of GH levels:case report and review.Endocrinologist,2003,13:3:169-172.
  • 9Merola B,Cittadini A.Colao A,et al.Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly.J Clln Endocrinol Metab,1993,77:3:790-793.
  • 10Maison P,Tropeano AJ,Macquin-Mavier I,et al.Impact of somatostatin analogs on the heart in acromegaly:a metaanalysis.J Clin Endocrinol Metab,2007,92:1743-1747.

共引文献7

中华内分泌代谢杂志
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部